Russ Johannesson, CEO, Glooko
Glooko connects people with diabetes and their healthcare professionals to enable telehealth and improved collaboration, in 26 countries across 15 languages.
But what makes Glooko’s solution so impactful?
This software platform connects people with diabetes with healthcare providers paving the way for stronger collaboration. Looking under the hood, the solution allows people with diabetes to upload and share data from diabetes devices with their providers, remotely or in person, and thoroughly explore it, for better decision making. It is deeply embedded in the existing clinical workflow for meaningful interactions and relieves health systems and care providers from downloading multiple software to handle increasingly different types of patient data.
“Today, people with diabetes use a myriad of devices, including blood glucose meters, continuous glucose monitors, insulin pumps, connected insulin pens, and activity trackers, to track their health,” says Russ Johannesson, CEO of Glooko. “As a device-agnostic solution provider, we believe that it is important to give care providers, diabetologists, primary care physicians, and patients total control over the choice of specific devices that are best suited for their care. With consistent access to patient data and uniquely personalized insights enabled by Glooko’s solution, providers can gain useful and accurate insights—in a graphical format—into patient health and make better clinical decisions. Patients, by the same token, can use those insights to make better self-management decisions related to their diabetes care.
This proven solution has made Glooko incredibly valuable in the current age of the COVID-19 pandemic.
The company has made its remote care solution free for any care provider or patient to use its solution in an effort to keep patients and providers safe during the pandemic. The company’s remote patient monitoring solution has witnessed a 100 percent increase in the number of patients registering for it. Moreover, more than 100 health systems and hospitals have subscribed to the no-charge solution during the COVID-19 pandemic. And it is not surprising. Why so? It is because Glooko prioritizes safety. Patients can share their data from the comfort and safety of their homes and sustain their access to care, effortlessly, without having to go into a clinic to see the doctor physically.
A case in point, Glooko’s Chief Medical Officer and Pediatric Endocrinologist Dr. Mark Clements and his colleagues in Kansas City, Missouri, have moved their care delivery services for patients to 100 percent online. Glooko’s solution, with secure sync capabilities, has been a shot in the arm for the organization during this challenging time.
Apart from its rich functionality, Glooko shines with its ease of use. The solution is cloud-based and does not require any installation. Patients can easily upload their data directly into the solution remotely through a mobile application. They can also share it with the existing system at the clinic, wirelessly.
On the privacy and security front, Glooko has been heavily investing in regulatory compliance to ensure the highest security and confidentiality in storing patient data. The company maintains regulatory compliance with HIPAA, GDPR, and various other compliance policies across the globe. In addition, it has Privacy Shield, HITRUST, and ISO 13485 certification for its quality management. All in all, Glooko has the right infrastructure, processes, and certifications in place to cater to the vast demands of large health systems, pharma companies, clinical research organizations, and payers.
Currently, Glooko offers two different versions of its solution, but with similar features. While the Glooko® Enterprise platform is offered in North America, diasend® is dedicated to clients in EMEA/APAC. To strengthen its value proposition in the market, Glooko has several ongoing partnerships, including device integration and data licensing agreements with all the major players in the diabetes world.
Marching ahead, Glooko plans to boost remote data monitoring and telehealth through its strategic partnerships. The company looks forward to helping its partners accelerate virtual clinical trials through the Glooko platform, and the breadth of patients subscribed to it.